Oscillate is the first public listed investment issuer in the UK with an approved investment strategy focusing on the medical psychedelic industry.
The Directors will be focused on making investments in both public and private businesses or assets in the medical psychedelic industry. medical psychedelic investments encompas the development of potential treatments for mental health issues, which include, but are not limited to:

Drug-resistant depression
Post-Traumatic Stress Disorder


Oscillate Plc is active reviewing investment opportunities in the medical cannabis sector, specifically the developing market for medicinal or therapeutic Cannabis derivative, or related products, including but not limited to nutraceuticals, dietary supplements and cosmetic products which contain cannabis or hemp derived cannabinoids.


Oscillate Plc has a open view on investments. Due to Oscillates main focus on the the medical field. The Directors are well connected to provide profitable opportunities in an array of fields. Our Directors influence and understanding of the Mining, Tech and Social Science industry allows spectacular opportunities to a profitable investment